A Merck KGaA plant in Goa, India, has run into labor issues over wages and is now having to take steps to avoid product shortages.

Dr. Reddy’s Laboratories said regulatory problems with its substitute supplier may keep it from getting to market this quarter with a generic of blockbuster…

WuXi AppTec subsidiary STA has bulked up with a new pilot plant and a fresh batch of R&D scientists trained at the company’s Shanghai R&D site.

New Jersey-based CDMO Catalent grew its revenues in the second quarter but saw a significant fall in net earnings, but still beat analysts forecasts. It has…

Dublin-base Alkermes intends to increase capacity and add nearly 100 jobs to the Ohio plant that manufactures its opioid abuse drug Vivitrol.

The FDA has caught an Italian drugmaker apparently manipulating testing data, reporting only passing tests even though original reports gave different results.

KBI Biopharma has picked up a plant in Texas from struggling Opexa Therapeutics, allowing the CDMO to move into clinical stage cell therapy production.

Novartis has withdrawn its applications for a biosimilar of Amgen’s blockbuster drug Neulasta after regulators in Europe raised questions about its…

A Brazilian antibiotics maker that was hammered in an FDA warning letter issued last month also caught the attention of the European Medicines Agency, which…

Supply Chain